Metagenomi
Sonya Cruz is an experienced professional in program management and business operations, currently serving as the Director of Program Management and Business Operations at Metagenomi since August 2022. Prior to this role, Sonya held positions at Supernus Pharmaceuticals, Inc. as Associate Director of R&D Project Management from November 2021 to August 2022, and at Adamas Pharmaceuticals, Inc. as Associate Director of Project Management for a brief period in 2021, following its acquisition by Supernus. Additionally, Sonya has experience as a Project Manager at Abbott from June 2019 to June 2021 and at BioMarin Pharmaceutical Inc., focusing on Medical Affairs Operations between August 2015 and May 2019. Earlier in the career, Sonya worked as a Senior Compliance Specialist and Associate Scientist at Bayer from November 2012 to August 2015.
Metagenomi
3 followers
Gene editing is changing the world. Founded by pioneers in the CRISPR/CAS revolution, Metagenomi is discovering the next generation of gene-editing systems for use in treating genetic diseases.